UBS Group AG Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on March 18, 2019, provides updated historical financial timeseries for UBS Group AG reflecting changes to cost and resource allocation methodologies and funds transfer pricing frameworks. The primary reporting period covered is the quarter and year ended December 31, 2018. The data is presented in US dollars, with comparative figures restated from Swiss francs.
Key Financial Metrics (Year Ended Dec 31, 2018)
| Metric | 2018 (USD Million) | 2017 (USD Million) |
|---|---|---|
| Operating Income | 30,213 | 29,622 |
| Operating Expenses | 24,222 | 24,272 |
| Operating Profit Before Tax | 5,991 | 5,351 |
| Net Profit Attributable to Shareholders | 4,516 | 969 |
| Diluted EPS (USD) | 1.18 | 0.25 |
| Return on Equity (ROE) | 8.6% | 1.8% |
| Cost/Income Ratio | 79.9% | 81.6% |
| Total Assets | 958,489 | 939,279 |
| Common Equity Tier 1 Capital Ratio | 12.9% | 13.8% |
| Liquidity Coverage Ratio | 136% | 143% |
Material Changes vs. Prior Period
- Profitability Surge: Net profit attributable to shareholders increased significantly to $4.516 billion in 2018, compared to $969 million in 2017. This improvement is largely driven by a massive tax benefit in 2017 (tax expense of $4.3 billion) versus a tax expense of $1.5 billion in 2018.
- Q4 2018 Performance: The fourth quarter of 2018 saw a sharp decline in operating profit to $481 million (down from $1.7 billion in Q3 2018) and net profit to $315 million. This was primarily due to a $533 million provision for litigation, regulatory, and similar matters, and a $270 million remeasurement loss related to UBS Securities China.
- Revenue Growth: Total operating income grew 2% year-over-year to $30.2 billion. Net fee and commission income increased to $17.9 billion.
- Capital Ratios: The Common Equity Tier 1 capital ratio decreased to 12.9% from 13.8% in 2017, while the Leverage Ratio remained stable at 3.77%.
Guidance, Outlook, and Risks
The filing contains historical data and does not provide forward-looking guidance or management commentary on future outlook. However, the data highlights specific risks and unusual items:
- Regulatory and Litigation Provisions: A significant $533 million expense was recognized in Q4 2018 for litigation and regulatory matters, indicating ongoing legal contingencies.
- Restructuring Costs: The group incurred $286 million in personnel-related and $275 million in non-personnel-related restructuring expenses in 2018.
- Investment Losses: A $270 million remeasurement loss related to UBS Securities China impacted Q4 2018 results.
- Market Risk: Management Value-at-Risk (VaR) for the group averaged $12 million in Q4 2018, with the Investment Bank division contributing the majority of market risk exposure.
Key Facts for Investor Verification
- Tax Impact: Verify the sustainability of the 2018 profit recovery, which was heavily influenced by the normalization of tax expenses following the exceptional $4.3 billion tax charge in 2017.
- Q4 Volatility: Investigate the specific nature of the $533 million litigation/regulatory provision and the $270 million China remeasurement loss to assess if these are one-time events or indicative of recurring risks.
- Cost Efficiency: Monitor the Cost/Income ratio, which improved to 79.9% in 2018 but spiked to 92.4% in Q4 2018 due to the aforementioned unusual items.
- Capital Adequacy: Confirm that the decline in the CET1 ratio to 12.9% remains comfortably above regulatory minimums and internal targets.
- Business Segment Performance: Note the divergence between the Investment Bank (which reported a pre-tax loss of $78 million in Q4) and the Global Wealth Management division (which reported a pre-tax profit of $327 million in Q4).